Emerald Advisers’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-20,407
Closed -$893K 274
2018
Q2
$893K Sell
20,407
-524
-3% -$24.6K 0.03% 188
2018
Q1
$1.05M Buy
20,931
+1,926
+10% +$113K 0.04% 180
2017
Q4
$1.25M Sell
19,005
-8,105
-30% -$515K 0.05% 167
2017
Q3
$1.62M Buy
27,110
+2,687
+11% +$160K 0.07% 151
2017
Q2
$1.58M Buy
24,423
+3,524
+17% +$223K 0.07% 148
2017
Q1
$1.3M Buy
20,899
+17,339
+487% +$1.04M 0.05% 176
2016
Q4
$206K Sell
3,560
-110,560
-97% -$6.53M 0.01% 252
2016
Q3
$6.78M Hold
114,120
0.3% 118
2016
Q2
$7.08M Buy
114,120
+10,920
+11% +$672K 0.34% 105
2016
Q1
$6.36M Hold
103,200
0.31% 107
2015
Q4
$6.28M Buy
103,200
+32,630
+46% +$1.94M 0.3% 109
2015
Q3
$3.57M Buy
+70,570
New +$3.76M 0.19% 152
2014
Q4
Sell
-76,134
Closed -$3.47M 360
2014
Q3
$3.47M Hold
76,134
0.21% 149
2014
Q2
$3.6M Hold
76,134
0.2% 151
2014
Q1
$3.5M Buy
76,134
+50
+0.1% +$2.31K 0.2% 152
2013
Q4
$3.69M Buy
76,084
+52,380
+221% +$2.45M 0.2% 150
2013
Q3
$1.03M Buy
23,704
+293
+1% +$12.5K 0.06% 241
2013
Q2
$959K Buy
+23,411
New +$976K 0.06% 239

Other funds holding XRAY

Emerald Advisers's XRAY Position: Q3 2018 in Review

Emerald Advisers sold out of Dentsply Sirona (XRAY) in Q3 2018, closing a stake of 20,407 shares — an estimated $893K sold.

Emerald Advisers first reported a position in XRAY in Q2 2013 and held it in 18 quarters. The position peaked at $7.08M in Q2 2016. 522 funds tracked by Wall St. Rank hold XRAY as of Q3 2018.

  • Emerald Advisers reported no remaining Dentsply Sirona position as of Q3 2018 after selling out during the quarter.
  • Emerald Advisers sold 20,407 Dentsply Sirona shares in Q3 2018, an estimated $893K.
  • Emerald Advisers first reported a position in Dentsply Sirona in Q2 2013 and held it in 18 quarters.
  • Emerald Advisers's Dentsply Sirona position peaked at $7.08M in Q2 2016.
  • 522 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2018.

Based on Emerald Advisers's 13F filing for Q3 2018, filed 31 Oct 2018.